Striding forward or getting too big for their boots? The developing role of data monitoring committees in clinical trials

被引：1
作者：
Tharmanathan, P. [1 ]
Calvert, M. J. [1 ]
Freemantle, N. [1 ]
机构：
[1] Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England
来源：
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | 2006年 / 31卷 / 02期
关键词：
D O I：
10.1111/j.1365-2710.2006.00709.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：111 / 118
页数：8
相关论文
共 32 条
  • [1] [Anonymous], 1988, CONTROL CLIN TRIALS, V9, P137
  • [2] *BRIT BROADC CORP, 1998, BUS COMP FIL BRIT BI
  • [3] Role of external evidence in monitoring clinical trials: experience from a perinatal trial
    Brocklehurst, P
    Elbourne, D
    Alfirevic, Z
    [J]. BRITISH MEDICAL JOURNAL, 2000, 320 (7240) : 995 - 998
  • [4] The effect of cardiac resynchronization on morbidity and mortality in heart failure
    Cleland, JGF
    Daubert, J
    Erdmann, E
    Freemantle, N
    Gras, D
    Kappenberger, L
    Tavazzi, L
    Cleland, JGF
    Daubert, JC
    Erdmann, E
    Gras, D
    Kappenberger, L
    Klein, W
    Tavazzi, L
    Poole-Wilson, PA
    Rydén, L
    Wedel, H
    Wellens, HJJ
    Uretsky, B
    Thygesen, K
    Böcker, D
    Marijianowski, MMH
    Freemantle, N
    Calvert, MJ
    Christ, G
    Fruhwald, F
    Hofmann, R
    Krypta, A
    Leisch, F
    Pacher, R
    Rauscha, F
    Tavernier, R
    Thomsen, PEB
    Boesgaard, S
    Eiskjær, H
    Esperen, GT
    Haarbo, J
    Hagemann, A
    Korup, E
    Moller, M
    Mortensen, P
    Sogaard, P
    Vesterlund, T
    Huikuri, H
    Niemelä, KI
    Toivonen, L
    Bauer, F
    Cohen-Solal, A
    Crocq, C
    Djiane, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (15) : 1539 - 1549
  • [5] The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points
    Cleland, JGF
    Daubert, JC
    Erdmann, E
    Freemantle, N
    Gras, D
    Kappenberger, L
    Klein, W
    Tavazzi, L
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (04) : 481 - 489
  • [6] Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial
    Dargie, HJ
    Colucci, Y
    Ford, I
    Sendon, JLL
    Remme, W
    Sharpe, N
    Blank, A
    Holcslaw, TL
    [J]. LANCET, 2001, 357 (9266) : 1385 - 1390
  • [7] Design and methodology of the CAPRICORN trial - a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction
    Dargie, HJ
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2000, 2 (03) : 325 - 332
  • [8] DEMETS DL, 1982, BIOMETRIKA, V69, P661
  • [9] The agonising negative trend in monitoring of clinical trials
    DeMets, DL
    Pocock, SJ
    Julian, DG
    [J]. LANCET, 1999, 354 (9194) : 1983 - 1988
  • [10] Should data and safety monitoring boards share confidential interim data?
    Dixon, DO
    Lagakos, SW
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (01): : 1 - 6
1234